Can the water uptake of a one-phase amorphous drug–polymer blend be predicted from its components, and can a drug–polymer interaction parameter (χ23) be extracted from blend sorption isotherms with the ternary Flory–Huggins model?
No to both. Felodipine and indomethacin blends with PVP, HPMC or HPMCAS took up to about 64% less water than additivity predicts, and in the ternary model the drug–polymer term carried at most 0.16% of the interaction adjustment, so fitted χ23 values ranged from −20.4 to 26.9. ····
For felodipine–PVP, indomethacin–PVP, felodipine–HPMC and felodipine–HPMCAS at 25 °C, measured moisture uptake lay well below the weight-averaged sum of the components; the gap was largest near 25% PVP in the PVP blends and at 50–70% polymer in the cellulose blends, and the authors find it "reasonable to speculate" that it reflects drug–polymer interactions that change how water interacts with each component. ······ Because the drug–polymer term contributes negligibly to the ternary Flory–Huggins model and the model assumes that binary interactions are unchanged in the blend, they conclude that χ23 fitted to sorption data "cannot be used to unambiguously determine" drug–polymer interaction, and they "hypothesize" that the scatter comes from that assumption combined with the small term. ···· A mean water–blend parameter χ1,23 fell with polymer content in all four series, most for PVP, which they read as water affinity rising with polymer proportion and hygroscopicity ("clearly shows"). ··· Not measured: the drug–polymer and water–component interactions inside the blends, which carry both the explanation of the shortfall and the reason given for the χ23 scatter. ·
01Why this study
The polymers in solid dispersions are hygroscopic; the water lowers Tg and may let the drug crystallize.
Shamblin 1999, ref 7; Rumondor 2009, ref 8
The weight-averaged sum of the component isotherms matched sugar–PVP blends unless the sugar crystallized.
Shamblin 1999, ref 7; Zhang 2001, ref 9 ··
Ternary FH fits gave drug–PVP χ of 1.27–1.49, implying limited miscibility of blends known to be miscible.
Crowley 2002, ref 10 ··
More detail
What was already known. The introduction builds on these points:
- Why water matters. Miscible drug–polymer blends (amorphous solid dispersions) raise the solubility and dissolution rate of poorly water-soluble crystalline drugs, partly because the crystal lattice is destroyed, and the polymer inhibits crystallization. (refs 1–6) Most such polymers are somewhat hydrophilic and disordered, so the blends absorb more water than the amorphous drug alone; this can lower Tg considerably and "may lead" to crystallization, so the tendency of blends to sorb water needs to be understood, for stability as well as processing. (Shamblin 1999, ref 7; Rumondor 2009, ref 8)
- The additivity model. The simplest assumption is that a one-phase blend sorbs the weight-averaged sum of what its components sorb. Shamblin and Zografi found good agreement for colyophilized sucrose–PVP at 50 wt% PVP, but not at 20 wt% PVP or for sucrose–PVP/VA above 32% RH, where sucrose crystallized. Zhang and Zografi saw the same for sucrose–PVP and trehalose–PVP as long as the sugar stayed amorphous, and their ternary FH χ values for the sugar–water, sugar–PVP and water–PVP pairs were consistent with miscible pairs. (Shamblin 1999, ref 7; Zhang 2001, ref 9) ··
- The drug–PVP puzzle. Crowley and Zografi applied the same approach to indomethacin, ursodeoxycholic acid and indapamide with PVP. Additivity agreed for indomethacin–PVP at 60–90% PVP, but the drug–polymer χ from ternary FH fits came out at 1.27–1.49, indicating limited miscibility; they called this counterintuitive, since a single Tg, infrared spectroscopy and powder X-ray diffraction show the blends to be miscible. Later work places the indomethacin–PVP parameter "much lower". (Crowley 2002, ref 10; refs 11–14) ··
- The Flory–Huggins tools. Water uptake by an amorphous solid can be treated as dissolution and described by the binary FH equation; for water–PVP, χ of about 0.5 had been reported with the size ratio taken as infinite. (Flory 1953, ref 18; Hancock 1993, ref 19; Zhang 2000, ref 20) ··
What the paper set out to do. Evaluate several models for predicting the moisture sorption of binary amorphous blends and, in particular, test whether the ternary FH equation can explain the moisture sorption of one-phase blends of a hydrophobic drug with a hydrophilic polymer.
02How they approached it
Two poorly water-soluble drugs and three polymers of different hygroscopicity, each blend series made across the full composition range and measured from 5 to 95% RH at 25 °C; the same isotherms then go through four models of increasing complexity. ····
What was done
Drug and dried polymer dissolved, solvent evaporated, briefly melted→gravimetric sorption at 25 °C, one RH per run from 5 to 95%→uptake at the plateau.······
Weight-averaged sum of the component isotherms→deviation of each blend from additivity.·····
Binary FH fitted to each single component→χ with water.··
Ternary FH with the binary χ and a literature χ23→predicted indomethacin–PVP isotherms and the share of each interaction term; χ23 fitted to blend data.······
Pseudobinary FH with drug and polymer as one unit→mean χ1,23 per composition.··
More detail
What was done
- Blends. Each polymer was dried over phosphorous pentoxide for at least a week, mixed with the drug in a glove-box under dry air (RH below 15%), dissolved in ethanol (indomethacin–PVP) or 1:1 dichloromethane–ethanol (felodipine blends), and the solvent was removed on a rotary evaporator. After at least 12 h under vacuum each sample was held about a minute at 5 °C above the drug's melting point, cooled and gently ground. Blends made this way had earlier been shown to be miscible with a single Tg; this was not re-measured here. ·
- Sorption. About 10 mg was dried at below 2% RH for 3 h at 25 °C and then held at a single RH (5, 15 … 95%) until the weight levelled off, about 600 min for the neat amorphous drugs and about 1000 min for the blends. Only points without evidence of crystallization are reported; the detection method and replicates are not stated. ·
- Additivity. For every blend and RH the expected uptake is the weight-averaged sum of the drug and polymer uptakes, and the deviation of the data is expressed as a percentage of that prediction. ··
- Binary FH. Eq. 1 was fitted to each single-component isotherm (p/p0 0.15–0.85 or 0.95) by least squares on ln(p/p0), using the densities and volumes of Table I and size ratios of 16.7 (felodipine) and 14.9 (indomethacin); the size ratios used for the polymers are not stated. ·····
- Ternary FH. Eq. 2 was used in two ways: to predict indomethacin–PVP isotherms at 25 and 75% PVP from the binary χ values and a literature χ23 (ref 14, value not printed), and to fit χ23 to the felodipine–PVP and indomethacin–PVP isotherms. Rewritten as eq. 3, it split the interaction adjustment into water–drug, water–polymer and drug–polymer shares (Table II). ··
- Mean parameter. Eq. 4 treats drug plus polymer as one solid and gives one χ1,23 per composition; felodipine–PVP was fitted only at 15–65% RH because this blend separates into two phases at high RH. ·
Key equations
The water activity p/p0 follows from the volume fraction of water φ1 taken up, the size ratio x12 of solid to water, and one interaction parameter χ12; a large positive χ12 means water and solid mix poorly. Fitted to each pure component to get its χ with water.
The same idea for water (1), drug (2) and polymer (3): two water–component terms and one drug–polymer term with χ23. Used to predict blend isotherms from the binary parameters and to fit χ23. The paper prints the fourth term as φ3/13; x13 is meant.·
When eq. 2 is solved for ln φ1, these three terms adjust the entropic prediction for water–drug, water–polymer and drug–polymer interaction; Table II gives each one's share.·
The blend is treated as one solid with combined volume fraction φ23, and a single mean parameter χ1,23 captures how much water likes the mixture. Fitted per composition.
Terms used on this page
- Moisture sorption isotherm: water taken up at equilibrium (here g per 100 g dry solid) against relative humidity at fixed temperature.
- Water activity p/p0: RH divided by 100.
- Additivity: the assumption that a blend takes up the weight-averaged sum of what its components take up alone.
- Flory–Huggins interaction parameter χ: a number for how much two components dislike each other; negative means net attraction, positive net repulsion. For a small molecule in a polymer, χ above about 0.5 means the two cannot mix at all compositions.
- Volume fraction φ and size ratio x: the share of volume held by each component, and the volume of one molecule (or polymer chain) relative to a water molecule.
- Mean (mixed) interaction parameter χ1,23: a single χ between water and the drug–polymer blend treated as one material.
03Main findings
PVP sets the water uptake; blends gain water as polymer is added
At 95% RH PVP took up about 75 g water per 100 g, HPMC about 22 and HPMCAS about 12, while the amorphous drugs stayed near 1–2 g/100 g up to 85% RH. Blend uptake rose with polymer content, most steeply with PVP. ·······
More detail
The single components rank PVP ≫ HPMC > HPMCAS ≫ indomethacin > felodipine at every RH. At 75% RH PVP held about 33 g/100 g, HPMC about 10, HPMCAS about 6, indomethacin about 1.6 and felodipine about 1.1; at 85% RH the drugs reached about 2.1 and 1.3 g/100 g. Neither neat drug has a 95% RH point; only data without evidence of crystallization were reported. ·· (Fig. 1)
In every blend series uptake at a given RH rose with polymer content. At 85% RH felodipine–PVP rose from about 1.1 (no PVP) through about 6.8, 15.7, 29.3 and 35.7 to 50.0 g/100 g (25, 50, 75, 90 and 100% PVP), and indomethacin–PVP from about 2 to 49.9 over the same range. With the cellulose polymers the rise was far smaller: felodipine–HPMC about 1.3 to 16.0 and felodipine–HPMCAS about 1.3 to 8.2 g/100 g. The authors attribute the larger increases with PVP to its higher polarity, and hence hygroscopicity ("presumably"). ····· (Fig. 2)
Blends sorb far less water than the sum of their parts
Measured uptake was below the weight-averaged sum in every series: by up to about 64% for felodipine–PVP, 47% for felodipine–HPMC and 55% for felodipine–HPMCAS. Indomethacin–PVP at 25% PVP and 85% RH took up about 3.6 g/100 g against 14.0 predicted. ····
More detail
For felodipine–PVP every plotted deviation from additivity is positive (measured below predicted), from about 45–57% at 10% PVP and 43–64% at 25% PVP down to about 9–22% at 75% PVP and 2.4–21% at 90% PVP, across 15–85% RH. Indomethacin–PVP gave similar trends, but those data are not shown. ·· (Fig. 6)
The cellulose blends also fell below additivity, by about 16–47% for felodipine–HPMC and up to about 55% for felodipine–HPMCAS; one HPMCAS point is slightly negative (about −4.5% at 15% HPMCAS, 85% RH). ··
In Fig. 9 the additivity prediction for indomethacin–PVP at 25% PVP is far above the data at every RH (about 14.0 against 3.6 g/100 g at 85% RH), whereas at 75% PVP it stays within about 2 g/100 g of the data (about 38.0 against 36.0 at 85% RH). The authors read 75% PVP as "reasonably similar" to additivity. ··
The authors take additivity to require that the blend behaves like a physical mixture, with every water-binding group as available as in the pure materials; the abstract states that blend profiles "could not be reconstructed" this way. ·
The shortfall peaks at different compositions with PVP and with the cellulose polymers
For felodipine–PVP the shortfall was largest at 10–25% PVP (about 43–64%) and fell to about 2–21% at 90% PVP; the authors place the peak near a 1:1 ratio of drug hydrogen-bond donors to PVP repeat units (78:22 drug:PVP by weight). For HPMC and HPMCAS it peaked at 50–70% polymer and varied more with RH. ·····
More detail
Crowley and Zografi had proposed that the shortfall reflects specific drug–polymer interactions and should be largest at about one drug hydrogen-bond donor per PVP repeat-unit acceptor, which corresponds to 76:24 (indomethacin–PVP) and 78:22 (felodipine–PVP) by weight. The authors state that this "is indeed around" where their maximum reduction lies. In Fig. 6 the 15, 35 and 85% RH series of felodipine–PVP peak at 25% PVP (about 64, 56 and 52.5%), but the 25% RH series is higher at 10% PVP (about 56.5) than at 25% (about 43); the indomethacin–PVP data are not shown. ····
For felodipine–HPMC the deviation reached about 36–47% at 50% and 36.5–44.5% at 70% polymer, against about 16–31% at 85%. For felodipine–HPMCAS the 15% RH series peaked at about 55% (50% HPMCAS) and the 85% RH series at about 29% (70%); at 50% HPMCAS the deviation fell steadily with RH from about 55 to 25%. The authors describe the cellulose shortfall as smaller than with PVP and "much more dependent on RH". ·· (Figs. 7, 8)
The authors' explanation: unlike PVP, HPMC and HPMCAS carry several hydrogen-bond donors and acceptors per repeat unit, so water keeps sites to bind, and they have been suggested to interact more weakly with felodipine; "it is intuitive" that these blends are less affected, and it is "reasonable to speculate" that the size of the shortfall follows the nature of the drug–polymer interactions. No interaction was measured here. ··
The composition levels of the cellulose blends are not consistent between figures (Fig. 7 plots HPMC at 15, 25, 50, 70 and 85%, while Fig. 3 lists 10, 25, 50, 75 and 90%).
The binary model fits single components and ranks their liking for water
Binary FH fits gave χ with water of 3.27 for felodipine, 2.86 for indomethacin, 0.36 for PVP, 1.33 for HPMC and 1.62 for HPMCAS, with correlation coefficients above 0.985. ·
More detail
The fits used p/p0 from 0.15 to 0.85 or 0.95 and size ratios of 16.7 (felodipine) and 14.9 (indomethacin). The large positive values for the drugs mark unfavourable mixing with water, as expected for hydrophobic drugs, with indomethacin slightly less unfavourable than felodipine. HPMC and HPMCAS lie above 0.5, in line with both polymers being relatively insoluble in water. PVP's 0.36 is called similar to, but slightly smaller than, the literature value of about 0.5. Crowley and Zografi had reported 3.13 for water–indomethacin from a single point at p/p0 0.8 with a size ratio of 2. ····
Extractor check: recomputing point values of χ from the Fig. 1 isotherms with eq. 1 and the Table I constants brackets the stated averages for both drugs, HPMC and HPMCAS, but gives about 0.47–0.75 for PVP, all above the stated 0.36. ·
The drug–polymer term of the ternary model is negligible, so χ23 cannot be pinned down
In the ternary model the drug–polymer term carried only 0.029–0.160% of the interaction adjustment; the water–drug term dominated up to 75% PVP. χ23 fitted to blend isotherms ranged from −9.6 to 26.9 for felodipine–PVP and −20.4 to 22.0 for indomethacin–PVP. ···
More detail
Prediction. With the binary parameters and the literature indomethacin–PVP χ23, eq. 2 tracked the 25% PVP data closely (about 3.8 against 3.6 g/100 g at 85% RH) but fell below the 75% PVP data at every RH (about 26.9 against 36.0 at 85% RH). The authors note that, without the interaction terms, the five entropic terms overpredicted uptake for both PVP systems, and that the positive water–drug and water–polymer χ and the negative χ23 brought the prediction closer ("suggesting" unfavourable enthalpic contributions). ··
Term shares (Table II). For indomethacin–PVP the water–drug share fell from 98.34% at 10% PVP to 68.97% at 75% and 42.64% at 90%, the water–polymer share rose from 1.63 to 57.24%, and the drug–polymer share stayed between 0.034 and 0.160%. Felodipine–PVP was almost identical (drug–polymer 0.029–0.143%). So up to 75% PVP most of the reduction in water uptake is attributed to the drug, and the drug–polymer term is negligible throughout. The authors say this "highlights the insensitivity" of the ternary equation to χ23, as Zhang and Zografi had also noted. ···
Fitted χ23. Because the χ23 term is so small, any small change of χ12 or χ13 inside the blend is absorbed by χ23, which "may not be physically meaningful or even show the correct trend". The fitted values ranged from −9.6 to 26.9 (felodipine–PVP) and −20.4 to 22.0 (indomethacin–PVP); the individual values, compositions and RH are not given. ·
The model assumes that water–drug, water–polymer and drug–polymer interactions in the blend equal those of the binaries. The authors consider this "unlikely": drug–polymer interactions "would most likely" change how water interacts with each component, and water changes the drug–polymer interactions, as solvent sorption studies of copolymers and polymer blends illustrate. ···
Extractor check: the Table II split for indomethacin–PVP is reproduced from the stated χ values, but the felodipine–PVP split matches only if a water–felodipine χ of about 2.9 rather than 3.27 is used; the RH and χ23 values behind Table II are not stated. ··
A mean water–blend parameter falls smoothly with polymer content
χ1,23 dropped from about 3.27 (neat felodipine) to about 0.37 at 100% PVP, 1.32 at 100% HPMC and 1.61 at 100% HPMCAS, and from about 2.87 to 0.37 for indomethacin–PVP; the drop was steepest with PVP. ··
More detail
Treating drug and polymer as one solid (eq. 4) removes the need to assume that χ12 and χ13 are unchanged in the blend. χ1,23 decreased steadily with polymer content in all four series; for felodipine–PVP about 3.27, 2.84, 2.41, 1.58, 0.96 and 0.78 at 0, 10, 25, 50, 75 and 90% PVP, almost the same as indomethacin–PVP from 50% PVP upward. With HPMC and HPMCAS the fall was shallower (about 2.34 and 2.59 at 50% polymer). The authors read the fall as rising affinity of water for the solid mixture as the hydrophilic component increases, and the steeper fall with PVP as following its higher hygroscopicity ("can be explained"). ···
They argue that treating the blend as a new solid matrix "seems more appropriate" for intimately mixed blends and is "particularly useful" because it needs no binary parameters in advance; the abstract says it "was found to better describe" the changing water affinity. No goodness of fit or recalculated isotherm is reported, and felodipine–PVP was fitted only at 15–65% RH. ····
04Further observations
- At 75% PVP, additivity roughly matches the indomethacin–PVP data, while the ternary model underpredicts by about a quarter. ·
- The felodipine–HPMCAS shortfall falls with RH and turns slightly negative at 15% HPMCAS and 85% RH. ·
- Blends needed about 1000 min to level off at each RH, the neat drugs about 600 min.
- The authors' χ for water–indomethacin (2.86) is close to an earlier single-point value (3.13). ·
More detail
- Additivity and eq. 2 fail in opposite places. For indomethacin–PVP, additivity overpredicts strongly at 25% PVP (about 14.0 against 3.6 g/100 g at 85% RH) but stays within about 2 g/100 g of the data at 75% PVP; eq. 2 matches 25% PVP (about 3.8) but underpredicts 75% PVP (about 26.9 against 36.0). The text names the additivity model as underpredicting at 75%, which the figure shows for eq. 2. ··
- RH dependence with HPMCAS. At 50% HPMCAS the deviation from additivity falls from about 55% (15% RH) through 47.6 and 43.8% (25 and 35% RH) to about 25% (85% RH). At 15% HPMCAS the 85% RH point is about −4.5%, the only case where a blend took up more than additivity predicts.
- Slow equilibration. Each RH was a separate experiment held until the weight levelled off, about 600 min for the neat amorphous drugs and about 1000 min for the blends.
- Literature comparisons. Water–indomethacin χ was 2.86 here against 3.13 from a single point at p/p0 0.8 in earlier work; water–PVP 0.36 here against about 0.5 in the literature. ···
- High-RH felodipine–PVP. Felodipine–PVP separates into two phases at high RH (earlier work), so the mean-parameter fit left out data above 65% RH; the same points are still used in the additivity comparison. ··
05How the authors connect the findings
More detail
- Polymers in solid dispersions are hygroscopic and the drugs are hydrophobic, so the polymer governs uptake: PVP sorbs most, HPMCAS least, and blend uptake rises with polymer content, more with PVP, "presumably" because PVP is more polar. ···
- Additivity assumes that the blend behaves like a physical mixture, with every group that binds water in the pure materials equally able to do so in the blend. The measured shortfall shows that this fails for all four systems. ··
PVP blends. Following Crowley and Zografi, drug–PVP hydrogen bonds use the hydrogen-bond donor of the drug and the acceptor of the PVP repeat unit; the largest shortfall is expected near a 1:1 ratio, 76:24 (indomethacin) and 78:22 (felodipine) by weight, which "is indeed around" where it is seen. ··
Cellulose blends. HPMC and HPMCAS have multiple donors and acceptors per repeat unit and have been suggested to interact more weakly with felodipine; if specific drug–polymer interaction causes the shortfall, "it is intuitive" that these blends are less affected.
- The ternary model assumes that binary interactions carry over unchanged into the blend; the authors consider this "unlikely". Since the drug–polymer term is at most 0.160% of the adjustment, small real changes of χ12 or χ13 inside the blend show up as large swings of fitted χ23. Abstract: "It is thought"; conclusions: "It is hypothesized". ····
What sets the size of the shortfall. The nature of the drug–polymer interactions and how they affect water's ability to interact with each component: strong drug–PVP hydrogen bonding at a single acceptor gives a large shortfall; weaker drug binding to polymers with many sites gives a smaller one. The authors offer this as speculation. ·
Conclusion drawn. The ternary FH extraction "cannot be used to unambiguously determine drug–polymer interaction parameters in solid dispersions", and "care must be taken" when applying FH to blends. A mean parameter that treats the blend as one unit relaxes the problematic assumption, needs no binary parameters, and "clearly shows" that water affinity rises with polymer proportion and polymer hygroscopicity. ····
06What it means for formulation
- Water uptake of a dispersion matters for its stability and processing, since water lowers Tg and may let the drug crystallize.
- Drug–polymer χ should not be taken from ternary FH fits of sorption isotherms. ·
- Adding the component isotherms overestimates a blend's water uptake, by up to about two-thirds at low PVP content: at most a conservative upper bound.
More detail
- Hygroscopic polymers make blends absorb more water than the amorphous drug alone; the resulting Tg decrease "may lead" to crystallization, so the moisture sorption of blends is important for stability as well as processing.
- Ternary FH fitting of sorption data "cannot be used to unambiguously determine" drug–polymer interaction parameters, and "care must be taken" when applying FH, successful for single amorphous solids, to blends. ·
- The mean-parameter approach is "particularly useful" because it needs no a priori binary parameters, and it describes how water affinity changes with polymer content and type. ·
- A weight-averaged sum of the component isotherms overestimates blend uptake, by up to about two-thirds at 10–25% PVP and about half at 50% HPMCAS in these systems; it gives an upper bound for a stability assessment, not a prediction. Measuring the blend's own isotherm is the safer basis.
- At the same polymer content, HPMCAS and HPMC blends took up several times less water than PVP blends at high RH, consistent with choosing a less hygroscopic polymer when moisture is the main risk.
- Drug–polymer χ for miscibility or loading decisions is better taken from methods that do not depend on water, such as melting point depression (the source of the literature value used here), than from sorption isotherms.
- The mean parameter χ1,23 is fitted per composition, so it describes measured isotherms rather than predicting new compositions.
07Open questions
- Do drug–polymer interactions really change how water interacts with the drug and the polymer inside the blend? Proposed, not measured. ·
- No spectroscopic or other direct evidence that drug–polymer hydrogen bonds take sites away from water.
- The stated water–PVP χ (0.36) does not follow from the plotted PVP isotherm.
More detail
- Whether drug–polymer interactions change water–drug and water–polymer interactions in the blend, and water changes drug–polymer interactions, is argued from literature on other systems; the paper does not measure it. ··
- Whether the size of the shortfall follows the nature and strength of the drug–polymer interactions is offered as speculation.
- No measurement of drug–polymer or water–component interactions in these blends (for example infrared spectroscopy at controlled RH) tests the site-competition picture.
- The stated χwater–PVP of 0.36 lies below every point value implied by the Fig. 1 isotherm, and the felodipine–PVP row of Table II matches a different water–felodipine χ than stated. ·
- Whether χ1,23 can predict isotherms of compositions, RH ranges or temperatures it was not fitted to is not tested; no fit quality is reported.
- Felodipine–PVP data at 75% RH and above may come from phase-separated blends, but they remain in the additivity comparison.
- Only 25 °C, two drugs and three polymers were studied, and replicates are not stated.
08How solid
AI assessment, not a statement made in the paperThe shortfall against additivity and the negligible drug–polymer term in the ternary model are large, consistent effects. The explanation of the shortfall by drug–polymer interactions is speculation, and several reported values (water–PVP χ, the felodipine row of Table II, the cellulose compositions) do not reconcile on recalculation. ·····
More detail
- The blend isotherms agree with the single-component isotherms at their end points, and the plotted additivity predictions can be recomputed from Fig. 1. ··
- The shortfall against additivity is large (up to about 64%) and seen in all four systems. ···
- The insensitivity of the ternary model to χ23 follows from the model's own arithmetic: the drug–polymer share is at most 0.160%, and the indomethacin–PVP split is reproducible from the stated parameters. ·
- The wide χ23 ranges (−20.4 to 26.9) demonstrate the ambiguity directly.
- The mechanism (drug–polymer binding taking sites from water; binary parameters changing in the blend) is not measured. ·
- The stated water–PVP χ cannot be recovered from the plotted isotherm, and the felodipine–PVP split in Table II needs an unstated water–felodipine χ; Table II gives no RH or χ23 values. ··
- The composition levels of HPMC and HPMCAS blends differ between figures, and eq. 3 carries sign and subscript misprints. ··
- The claim that the mean parameter "better describes" the data rests on fitted values without fit statistics.
- The peak of the felodipine–PVP shortfall is at 10–25% PVP depending on RH, and the indomethacin–PVP data supporting the 76:24 match are not shown.
- Isotherms appear to be single runs, crystallization screening is not described, and high-RH felodipine–PVP data may be phase separated. ·
09Figure guide
Every figure and table of the paper, what it is there for, and what to check on the original. Key figures are shown with the story.
| Figure | What it does in the paper | Supports | Check (AI note) |
|---|---|---|---|
| Fig. 1 (p.1057)key figure | Baseline isotherms of the five pure components: PVP far above HPMC and HPMCAS, amorphous drugs lowest. | F1 | No 95% RH point for either neat drug, without comment. |
| Fig. 2 (p.1057)key figure | Felodipine–PVP isotherms at seven compositions; uptake rises with PVP. | F1 | Points at 75% RH and above may come from phase-separated blends. |
| Fig. 3 (p.1057) | Felodipine–HPMC isotherms; much lower uptake than with PVP. | F1 | Legend levels differ from the compositions plotted in Fig. 7. |
| Fig. 4 (p.1058) | Felodipine–HPMCAS isotherms; the lowest-uptake series. | F1 | Legend levels differ from the compositions plotted in Fig. 10. |
| Fig. 5 (p.1058) | Indomethacin–PVP isotherms, close to felodipine–PVP. | F1 | |
| Fig. 6 (p.1058)key figure | Felodipine–PVP shortfall against additivity, about 43–64% at 10–25% PVP down to 2–21% at 90%. | F2, F3 | One RH series peaks at 10%, not 25% PVP. |
| Fig. 7 (p.1058)key figure | Felodipine–HPMC shortfall, highest at 50–70% polymer. | F3 | Plotted at 15, 25, 50, 70 and 85% HPMC, not the Fig. 3 levels. |
| Fig. 8 (p.1059)key figure | Felodipine–HPMCAS shortfall, up to about 55% at 50% polymer, strongly RH dependent. | F3, K2 | |
| Table I (p.1059) | Densities, molecular weights and volumes used in every FH calculation. | 0.2 | Molecular-volume unit misprinted as cm³/mol. |
| Fig. 9 (p.1060)key figure | Test of the ternary model for indomethacin–PVP: good at 25% PVP, low at 75% PVP; additivity far too high at 25% PVP. | F5, F2 | The text names additivity, not eq. 2, as underpredicting at 75% PVP. |
| Table II (p.1061)key figure | The core evidence that the drug–polymer term is negligible (at most 0.160%). | F5, K5 | Felodipine row not reproduced with the stated χ; RH and χ23 not stated.· |
| Fig. 10 (p.1062)key figure | The proposed alternative: χ1,23 falls with polymer content, most with PVP. | F6, K7 | HPMCAS plotted at 10, 25, 50, 75, 90%; no fit statistics.· |